Short Interest in Cibus, Inc. (NASDAQ:CBUS) Drops By 8.7%

Cibus, Inc. (NASDAQ:CBUS) was the target of a large decline in short interest during the month of January. As of January 31st, there was short interest totalling 2,110,000 shares, a decline of 8.7% from the January 15th total of 2,310,000 shares. Approximately 10.2% of the shares of the stock are sold short. Based on an average trading volume of 166,400 shares, the short-interest ratio is presently 12.7 days.

Cibus Stock Performance

Shares of NASDAQ CBUS traded down $0.06 during midday trading on Monday, reaching $2.53. The stock had a trading volume of 65,134 shares, compared to its average volume of 144,728. The company’s 50 day moving average price is $2.77 and its 200 day moving average price is $4.20. Cibus has a twelve month low of $2.16 and a twelve month high of $23.18. The firm has a market cap of $66.94 million, a price-to-earnings ratio of -0.11 and a beta of 1.82.

Institutional Trading of Cibus

A number of large investors have recently bought and sold shares of the business. FMR LLC increased its stake in shares of Cibus by 16.9% in the 3rd quarter. FMR LLC now owns 3,913,279 shares of the company’s stock valued at $12,757,000 after acquiring an additional 566,328 shares in the last quarter. Granby Capital Management LLC grew its holdings in Cibus by 300.0% in the fourth quarter. Granby Capital Management LLC now owns 200,000 shares of the company’s stock worth $556,000 after purchasing an additional 150,000 shares during the period. Renaissance Technologies LLC increased its stake in Cibus by 933.3% in the fourth quarter. Renaissance Technologies LLC now owns 127,100 shares of the company’s stock valued at $353,000 after purchasing an additional 114,800 shares in the last quarter. State Street Corp raised its holdings in shares of Cibus by 43.6% during the third quarter. State Street Corp now owns 307,262 shares of the company’s stock valued at $1,002,000 after purchasing an additional 93,236 shares during the period. Finally, Certior Financial Group LLC bought a new position in shares of Cibus during the 4th quarter worth about $236,000. 33.81% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several research firms have recently weighed in on CBUS. HC Wainwright restated a “buy” rating and set a $25.00 price target on shares of Cibus in a report on Monday, November 11th. Canaccord Genuity Group reduced their target price on shares of Cibus from $20.00 to $18.00 and set a “buy” rating on the stock in a report on Wednesday, January 22nd.

About Cibus

Cibus, Inc, a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases.